Gelfand, Jeffrey M <br/><br/>
Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series.  [electronic resource] 

 -  Neurology  Nov 2017 
 - 2092-2100 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1526-632X 
<br/><br/><label>Standard No.: </label>10.1212/WNL.0000000000004644  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Central Nervous System Diseases--drug therapy<br/>Female<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Infliximab--administration & dosage<br/>Male<br/>Middle Aged<br/>Outcome Assessment, Health Care<br/>Sarcoidosis--drug therapy<br/>Tumor Necrosis Factor-alpha--immunology<br/>Young Adult